FI (list display)

A61K31/00	Medicinal preparations containing organic active ingredients [2]	(Note)/(Index)	HB	CC	4C206

A61K31/01	.Hydrocarbons [2]		HB	CC	4C206

A61K31/015	..carbocyclic [2]		HB	CC	4C206

A61K31/02	.Halogenated hydrocarbons [2]		HB	CC	4C206

A61K31/025	..carbocyclic [2]		HB	CC	4C206

A61K31/03	...aromatic [2]		HB	CC	4C206

A61K31/035	..having aliphatic unsaturation [2]		HB	CC	4C206

A61K31/04	.Nitro compounds [2]		HB	CC	4C206

A61K31/045	.Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates (hydroperoxides A61K 31/327) [2,7]		HB	CC	4C206

A61K31/047	..having two or more hydroxy groups, e.g. sorbitol [7]		HB	CC	4C206

A61K31/05	..Phenols [2]		HB	CC	4C206

A61K31/055	...the aromatic ring being substituted by halogen [2]		HB	CC	4C206

A61K31/06	...the aromatic ring being substituted by nitro groups [2]		HB	CC	4C206

A61K31/065	..Diphenyl-substituted acyclic alcohols [2]		HB	CC	4C206

A61K31/07	..Retinol compounds, e.g. vitamin A (retinoic acids A61K 31/203) [2,7]		HB	CC	4C206

A61K31/075	.Ethers or acetals [2]		HB	CC	4C206

A61K31/08	..acyclic, e.g. paraformaldehyde [2]		HB	CC	4C206

A61K31/085	..having an ether linkage to aromatic ring nuclear carbon [2]		HB	CC	4C206

A61K31/09	...having two or more such linkages [2]		HB	CC	4C206

A61K31/095	.Sulfur, selenium or tellurium compounds, e.g. thiols [2]		HB	CC	4C206

A61K31/10	..Sulfides; Sulfoxides; Sulfones [2]		HB	CC	4C206

A61K31/105	..Persulfides (thiuram disulfides A61K 31/145; thiosulfonic acids A61K 31/185) [2]		HB	CC	4C206

A61K31/11	.Aldehydes [2]		HB	CC	4C206

A61K31/115	..Formaldehyde [2]		HB	CC	4C206

A61K31/12	.Ketones [2]		HB	CC	4C206

A61K31/121	..acyclic [7]		HB	CC	4C206

A61K31/122	..having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K₁, anthralin [7]		HB	CC	4C206

A61K31/125	...Camphor; Nuclear substituted derivatives thereof [2]		HB	CC	4C206

A61K31/13	.Amines, e.g. amantadine (A61K 31/04 takes precedence) [2]		HB	CC	4C206

A61K31/131	..acyclic [7]		HB	CC	4C206

A61K31/132	..having two or more amino groups, e.g. spermidine, putrescine [7]		HB	CC	4C206

A61K31/133	..having hydroxy groups, e.g. sphingosine [7]		HB	CC	4C206

A61K31/135	..having aromatic rings, e.g. methadone [2,7]		HB	CC	4C206

A61K31/136	...having the amino group directly attached to the aromatic ring, e.g. benzeneamine [7]		HB	CC	4C206

A61K31/137	...Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine [7]		HB	CC	4C206

A61K31/138	...Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine (atenolol A61K 31/165; pindolol A61K 31/404; timolol A61K 31/5377) [7]		HB	CC	4C206

A61K31/14	..Quaternary ammonium compounds, e.g. edrophonium, choline (betaines A61K 31/205) [2]		HB	CC	4C206

A61K31/145	..having sulfur atoms, e.g. thiurams (2) (isothioureas A61K 31/155) [2,7]		HB	CC	4C206

A61K31/15	..Oximes (		HB	CC	4C206

A61K31/155	..Amidines ([figure]), e.g. guanidine (H₂N—C(=NH)—NH₂), isourea (HN=C(OH)NH₂), isothiourea (HN=C(SH)—NH₂) [2]		HB	CC	4C206

A61K31/16	.Amides, e.g. hydroxamic acids [2]		HB	CC	4C206

A61K31/164	..of a carboxylic acid with an aminoalcohol, e.g. ceramides [7]		HB	CC	4C206

A61K31/165	..having aromatic rings, e.g. colchicine, atenolol, progabide [2]		HB	CC	4C206

A61K31/166	...having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol [7]		HB	CC	4C206

A61K31/167	...having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol [7]		HB	CC	4C206

A61K31/17	..having the group		HB	CC	4C206

A61K31/175	...having the group [figure], figure], e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof [2,7]		HB	CC	4C206

A61K31/18	..Sulfonamides (compounds containing a para-N-benzene-sulfonyl-N-group A61K 31/63) [2]		HB	CC	4C206

A61K31/185	.Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids (hydroxamic acids A61K 31/16; peroxy acids A61K 31/327) [2,7]		HB	CC	4C206

A61K31/19	..Carboxylic acids, e.g. valproic acid (salicylic acid A61K 31/60) [2,7]		HB	CC	4C206

A61K31/191	...Acyclic acids having two or more hydroxy groups, e.g. gluconic acid [7]		HB	CC	4C206

A61K31/192	...having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid [7]		HB	CC	4C206

A61K31/194	...having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid [7]		HB	CC	4C206

A61K31/195	...having an amino group	(Note)/(Index)	HB	CC	4C206

A61K31/196	....the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil [7]		HB	CC	4C206

A61K31/197	....the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid (carnitine A61K 31/205) [2006.01]		HB	CC	4C206

A61K31/198	.....Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K 31/205; proline A61K 31/401; tryptophan A61K 31/405; histidine A61K 31/4172; peptides not degraded to individual amino acids A61K 38/00) [2006.01]		HB	CC	4C206

A61K31/20	...having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid [2]		HB	CC	4C206

A61K31/201	....having one or two double bonds, e.g. oleic or linoleic acid [7]		HB	CC	4C206

A61K31/202	....having three or more double bonds, e.g. linolenic acid (eicosanoids, e.g. leukotrienes, A61K 31/557) [7]		HB	CC	4C206

A61K31/203	....Retinoic acids [7]		HB	CC	4C206

A61K31/205	..Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine [2]		HB	CC	4C206

A61K31/21	.Esters, e.g. nitroglycerine, selenocyanates [2]		HB	CC	4C206

A61K31/215	..of carboxylic acids [2]		HB	CC	4C206

A61K31/216	...of acids having aromatic rings, e.g. benactizyne, clofibrate [7]		HB	CC	4C206

A61K31/22	...of acyclic acids, e.g. pravastatin [2]		HB	CC	4C206

A61K31/221	....with compounds having an amino group, e.g. acetylcholine, acetylcarnitine [7]		HB	CC	4C206

A61K31/222	....with compounds having aromatic groups, e.g. dipivefrine, ibopamine [7]		HB	CC	4C206

A61K31/223	....of alpha-amino acids [7]		HB	CC	4C206

A61K31/225	....Polycarboxylic acids [2]		HB	CC	4C206

A61K31/23	....of acids having a carboxyl group bound to a chain of seven or more carbon atoms [2]		HB	CC	4C206

A61K31/231	.....having one or two double bonds [7]		HB	CC	4C206

A61K31/232	.....having three or more double bonds, e.g. etretinate [7]		HB	CC	4C206

A61K31/235	...having an aromatic ring attached to a carboxyl group [2]		HB	CC	4C206

A61K31/24	....having an amino or nitro group [2]		HB	CC	4C206

A61K31/245	.....Amino benzoic acid types, e.g. procaine, novocaine (salicylic acid esters A61K 31/60) [2]		HB	CC	4C206

A61K31/25	...with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol [2]		HB	CC	4C206

A61K31/255	..of sulfoxy acids or sulfur analogues thereof [2]		HB	CC	4C206

A61K31/26	..Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters [2,7]		HB	CC	4C206

A61K31/265	..of carbonic, thiocarbonic or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid [2]		HB	CC	4C206

A61K31/27	..of carbamic or thiocarbamic acids, e.g. meprobamate, carbachol, neostigmine [2]		HB	CC	4C206

A61K31/275	.Nitriles; Isonitriles [2]		HB	CC	4C206

A61K31/277	..having a ring, e.g. verapamil [7]		HB	CC	4C206

A61K31/28	.Compounds containing heavy metals [2]		HB	CC	4C206

A61K31/282	..Platinum compounds [7]		HB	CC	4C206

A61K31/285	..Arsenic compounds [2]		HB	CC	4C206

A61K31/29	..Antimony or bismuth compounds [2]		HB	CC	4C206

A61K31/295	..Iron group metal compounds [2]		HB	CC	4C206

A61K31/30	..Copper compounds [2]		HB	CC	4C206

A61K31/305	..Mercury compounds [2]		HB	CC	4C206

A61K31/31	...containing nitrogen [2]		HB	CC	4C206

A61K31/315	..Zinc compounds [2]		HB	CC	4C206

A61K31/32	..Tin compounds [2]		HB	CC	4C206

A61K31/325	.Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof (thiurams A61K 31/145) [2]		HB	CC	4C206

A61K31/327	.Peroxy compounds, e.g. hydroperoxides, peroxides, peroxy acids [7]		HB	CC	4C206

A61K31/33	.Heterocyclic compounds [2]		HB	CC	4C086

A61K31/335	..having oxygen as the only ring hetero atom, e.g. fungichromin [2]		HB	CC	4C086

A61K31/336	...having three-membered rings, e.g. oxirane, fumagillin [7]		HB	CC	4C086

A61K31/337	...having four-membered rings, e.g. taxol [7]		HB	CC	4C086

A61K31/34	...having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide [2]		HB	CC	4C086

A61K31/341	....not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine [7]		HB	CC	4C086

A61K31/343	....condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone [7]		HB	CC	4C086

A61K31/345	....Nitrofurans (nitrofurantoin A61K 31/4178) [2,7]		HB	CC	4C086

A61K31/35	...having six-membered rings with one oxygen as the only ring hetero atom [2]		HB	CC	4C086

A61K31/351	....not condensed with another ring [7]		HB	CC	4C086

A61K31/352	....condensed with carbocyclic rings, e.g. cannabinols, methantheline [7]		HB	CC	4C086

A61K31/353	.....3,4-Dihydrobenzopyrans, e.g. chroman, catechin [7]		HB	CC	4C086

A61K31/355	......Tocopherols, e.g. vitamin E [2]		HB	CC	4C086

A61K31/357	...having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel [7]		HB	CC	4C086

A61K31/36	....Compounds containing methylenedioxyphenyl groups, e.g. sesamin [2]		HB	CC	4C086

A61K31/365	...Lactones [2]		HB	CC	4C086

A61K31/366	....having six-membered rings, e.g. delta-lactones [7]		HB	CC	4C086

A61K31/37	.....Coumarins, e.g. psoralen [2]		HB	CC	4C086

A61K31/375	....Ascorbic acid, i.e. vitamin C; Salts thereof [2]		HB	CC	4C086

A61K31/38	..having sulfur as a ring hetero atom [2]		HB	CC	4C086

A61K31/381	...having five-membered rings [7]		HB	CC	4C086

A61K31/382	...having six-membered rings, e.g. thioxanthenes (thiothixene A61K 31/496) [7]		HB	CC	4C086

A61K31/385	...having two or more sulfur atoms in the same ring [2]		HB	CC	4C086

A61K31/39	...having oxygen atoms in the same ring [2]		HB	CC	4C086

A61K31/395	.. having nitrogen as a ring hetero atom e.g. guanethidine or rifamycins		HB	CC	4C086

A61K31/396	...having three-membered rings, e.g. aziridine [7]		HB	CC	4C086

A61K31/397	...having four-membered rings, e.g. azetidine [7]		HB	CC	4C086

A61K31/40	...having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil [2]		HB	CC	4C086

A61K31/401	....Proline; Derivatives thereof, e.g. captopril [7]		HB	CC	4C086

A61K31/4015	....having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide [7]		HB	CC	4C086

A61K31/402	....1-aryl-substituted, e.g. piretanide [7]		HB	CC	4C086

A61K31/4025	....not condensed and containing further heterocyclic rings, e.g. cromakalim [7]		HB	CC	4C086

A61K31/403	....condensed with carbocyclic rings, e.g. carbazole [7]		HB	CC	4C086

A61K31/4035	.....Isoindoles, e.g. phthalimide [7]		HB	CC	4C086

A61K31/404	.....Indoles, e.g. pindolol [7]		HB	CC	4C086

A61K31/4045	......Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin [7]		HB	CC	4C086

A61K31/405	......Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin [2]		HB	CC	4C086

A61K31/407	....condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine [7]		HB	CC	4C086

A61K31/409	....having four such rings, e.g. porphine derivatives, bilirubin, biliverdine (hemin, hematin A61K 31/555) [7]		HB	CC	4C086

A61K31/41	...having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole [2]		HB	CC	4C086

A61K31/415	....1,2-Diazoles [2,7]		HB	CC	4C086

A61K31/4152	.....having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone [7]		HB	CC	4C086

A61K31/4155	.....not condensed and containing further heterocyclic rings [7]		HB	CC	4C086

A61K31/416	.....condensed with carbocyclic ring systems, e.g. indazole [7]		HB	CC	4C086

A61K31/4162	.....condensed with heterocyclic ring systems [7]		HB	CC	4C086

A61K31/4164	....1,3-Diazoles [7]		HB	CC	4C086

A61K31/4166	.....having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin [7]		HB	CC	4C086

A61K31/4168	.....having a nitrogen atom attached in position 2, e.g. clonidine [7]		HB	CC	4C086

A61K31/417	.....Imidazole-alkylamines, e.g. histamine, phentolamine [7]		HB	CC	4C086

A61K31/4172	.....Imidazole-alkanecarboxylic acids, e.g. histidine [7]		HB	CC	4C086

A61K31/4174	.....Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole [7]		HB	CC	4C086

A61K31/4178	.....not condensed and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin [7]		HB	CC	4C086

A61K31/4184	.....condensed with carbocyclic rings, e.g. benzimidazoles [7]		HB	CC	4C086

A61K31/4188	.....condensed with heterocyclic ring systems, e.g. biotin, sorbinil [7]		HB	CC	4C086

A61K31/4192	....1,2,3-Triazoles [7]		HB	CC	4C086

A61K31/4196	....1,2,4-Triazoles [7]		HB	CC	4C086

A61K31/42	....Oxazoles [2,7]		HB	CC	4C086

A61K31/421	.....1,3-Oxazoles, e.g. pemoline, trimethadione [7]		HB	CC	4C086

A61K31/422	.....not condensed and containing further heterocyclic rings [7]		HB	CC	4C086

A61K31/423	.....condensed with carbocyclic rings [7]		HB	CC	4C086

A61K31/424	.....condensed with heterocyclic ring systems, e.g. clavulanic acid [7]		HB	CC	4C086

A61K31/4245	....Oxadiazoles [7]		HB	CC	4C086

A61K31/425	....Thiazoles [2,7]		HB	CC	4C086

A61K31/426	.....1,3-Thiazoles [7]		HB	CC	4C086

A61K31/427	.....not condensed and containing further heterocyclic rings [7]		HB	CC	4C086

A61K31/428	.....condensed with carbocyclic rings [7]		HB	CC	4C086

A61K31/429	.....condensed with heterocyclic ring systems [7]		HB	CC	4C086

A61K31/43	......Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula [figure], e.g. penicillins, penems [2,6]		HB	CC	4C086

A61K31/431	.......containing further heterocyclic ring systems, e.g. ticarcillin, azlocillin, oxacillin [7]		HB	CC	4C086

A61K31/433	....Thiadiazoles [7]		HB	CC	4C086

A61K31/435	...having six-membered rings with one nitrogen as the only ring hetero atom [2]		HB	CC	4C086

A61K31/4353	....ortho- or peri-condensed with heterocyclic ring systems [7]		HB	CC	4C086

A61K31/4355	.....the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom [7]		HB	CC	4C086

A61K31/436	.....the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin [7]		HB	CC	4C086

A61K31/4365	.....the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine [7]		HB	CC	4C086

A61K31/437	.....the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline [7]		HB	CC	4C086

A61K31/4375	.....the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine [7]		HB	CC	4C086

A61K31/438	....the ring being spiro-condensed with carbocyclic or heterocyclic ring systems [7]		HB	CC	4C086

A61K31/439	....the ring forming part of a bridged ring system, e.g. quinuclidine (8-azabicyclo [3.2.1] octanes A61K 31/46) [7]		HB	CC	4C086

A61K31/44	....Non-condensed pyridines; Hydrogenated derivatives thereof [2,7]		HB	CC	4C086

A61K31/4402	.....only substituted in position 2, e.g. pheniramine, bisacodyl [7]		HB	CC	4C086

A61K31/4406	.....only substituted in position 3, e.g. zimeldine (nicotinic acid A61K 31/455) [7]		HB	CC	4C086

A61K31/4409	.....only substituted in position 4, e.g. isoniazid, iproniazid [7]		HB	CC	4C086

A61K31/4412	.....having oxo groups directly attached to the heterocyclic ring [7]		HB	CC	4C086

A61K31/4415	.....Pyridoxine, i.e.vitamin B₆ (pyridoxal phosphate A61K 31/675) [7]		HB	CC	4C086

A61K31/4418	.....having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine [7]		HB	CC	4C086

A61K31/4422	.....1,4-Dihydropyridines, e.g. nifedipine, nicardipine [7]		HB	CC	4C086

A61K31/4425	.....Pyridinium derivatives, e.g. pralidoxime, pyridostigmine [7]		HB	CC	4C086

A61K31/4427	.....containing further heterocyclic ring systems [7]		HB	CC	4C086

A61K31/443	......containing a five-membered ring with oxygen as a ring hetero atom [7]		HB	CC	4C086

A61K31/4433	......containing a six-membered ring with oxygen as a ring hetero atom [7]		HB	CC	4C086

A61K31/4436	......containing a heterocyclic ring having sulfur as a ring hetero atom [7]		HB	CC	4C086

A61K31/4439	......containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K 31/465) [7]		HB	CC	4C086

A61K31/444	......containing a six-membered ring with nitrogen as a ring hetero atom, e.g. amrinone [7]		HB	CC	4C086

A61K31/445	.....Non-condensed piperidines, e.g. piperocaine [2,7]		HB	CC	4C086

A61K31/4453	......only substituted in position 1, e.g. propipocaine, diperodon [7]		HB	CC	4C086

A61K31/4458	......only substituted in position 2, e.g. methylphenidate [7]		HB	CC	4C086

A61K31/4462	......only substituted in position 3 [7]		HB	CC	4C086

A61K31/4465	......only substituted in position 4 [7]		HB	CC	4C086

A61K31/4468	......having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl [7]		HB	CC	4C086

A61K31/45	......having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide [2,7]		HB	CC	4C086

A61K31/451	......having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine [7]		HB	CC	4C086

A61K31/4515	......having a butyrophenone group in position 1, e.g. haloperidol (pipamperone A61K 31/4545) [7]		HB	CC	4C086

A61K31/452	......Piperidinium derivatives (pancuronium A61K 31/58) [7]		HB	CC	4C086

A61K31/4523	......containing further heterocyclic ring systems [7]		HB	CC	4C086

A61K31/4525	.......containing a five-membered ring with oxygen as a ring hetero atom [7]		HB	CC	4C086

A61K31/453	.......containing a six-membered ring with oxygen as a ring hetero atom [7]		HB	CC	4C086

A61K31/4535	.......containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen [7]		HB	CC	4C086

A61K31/454	.......containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone [7]		HB	CC	4C086

A61K31/4545	.......containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine [7]		HB	CC	4C086

A61K31/455	.....Nicotinic acid, i.e. niacin; Derivatives thereof, e.g. esters, amides [2]		HB	CC	4C086

A61K31/46	....8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine [2]		HB	CC	4C086

A61K31/465	....Nicotine; Derivatives thereof [2]		HB	CC	4C086

A61K31/47	....Quinolines; Isoquinolines [2]		HB	CC	4C086

A61K31/4704	.....2-Quinolinones, e.g. carbostyril [7]		HB	CC	4C086

A61K31/4706	.....4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine [7]		HB	CC	4C086

A61K31/4709	.....Non-condensed quinolines containing further heterocyclic rings [7]		HB	CC	4C086

A61K31/472	.....Non-condensed isoquinolines, e.g. papaverine [7]		HB	CC	4C086

A61K31/4725	......containing further heterocyclic rings [7]		HB	CC	4C086

A61K31/473	.....ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines [7]		HB	CC	4C086

A61K31/4738	.....ortho- or peri-condensed with heterocyclic ring systems [7]		HB	CC	4C086

A61K31/4741	......condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline [7]		HB	CC	4C086

A61K31/4743	......condensed with ring systems having sulfur as a ring hetero atom [7]		HB	CC	4C086

A61K31/4745	......condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenanthrolines (yohimbine derivatives, vinblastine A61K 31/475; ergoline derivatives A61K 31/48) [7]		HB	CC	4C086

A61K31/4747	.....spiro-condensed [7]		HB	CC	4C086

A61K31/4748	.....forming part of bridged ring systems (strychnine A61K 31/475; morphinan derivatives A61K 31/485) [7]		HB	CC	4C086

A61K31/475	.....having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine (vincamine A61K 31/4375) [2,7]		HB	CC	4C086

A61K31/48	.....Ergoline derivatives, e.g. lysergic acid, ergotamine [2,7]		HB	CC	4C086

A61K31/485	.....Morphinan derivatives, e.g. morphine, codeine [2,7]		HB	CC	4C086

A61K31/49	.....Cinchonan derivatives, e.g. quinine [2,7]		HB	CC	4C086

A61K31/495	...having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine (A61K 31/48 takes precedence) [2]		HB	CC	4C086

A61K31/496	....Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin [2006.01]		HB	CC	4C086

A61K31/4965	....Non-condensed pyrazines [7]		HB	CC	4C086

A61K31/497	.....containing further heterocyclic rings [7]		HB	CC	4C086

A61K31/498	....Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine [7]		HB	CC	4C086

A61K31/4985	....Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems [7]		HB	CC	4C086

A61K31/499	....Spiro-condensed pyrazines or piperazines [7]		HB	CC	4C086

A61K31/4995	....Pyrazines or piperazines forming part of bridged ring systems [7]		HB	CC	4C086

A61K31/50	....Pyridazines; Hydrogenated pyridazines [2,7]		HB	CC	4C086

A61K31/501	.....not condensed and containing further heterocyclic rings [7]		HB	CC	4C086

A61K31/502	.....ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine [7]		HB	CC	4C086

A61K31/5025	.....ortho- or peri-condensed with heterocyclic ring systems [7]		HB	CC	4C086

A61K31/503	.....spiro-condensed [7]		HB	CC	4C086

A61K31/504	.....forming part of bridged ring systems [7]		HB	CC	4C086

A61K31/505	....Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim [2,7]		HB	CC	4C086

A61K31/506	.....not condensed and containing further heterocyclic rings [7]		HB	CC	4C086

A61K31/51	......Thiamines, e.g. vitamin B₁ [2]		HB	CC	4C086

A61K31/513	.....having oxo groups directly attached to the heterocyclic ring, e.g. cytosine [7]		HB	CC	4C086

A61K31/515	......Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital [2]		HB	CC	4C086

A61K31/517	.....ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine [7]		HB	CC	4C086

A61K31/519	.....ortho- or peri-condensed with heterocyclic rings [7]		HB	CC	4C086

A61K31/52	......Purines, e.g. adenine [2,7]		HB	CC	4C086

A61K31/522	.......having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir [7, 2006.01]		HB	CC	4C086

A61K31/525	......Isoalloxazines, e.g. riboflavins, vitamin B₂ [2]		HB	CC	4C086

A61K31/527	.....spiro-condensed [7]		HB	CC	4C086

A61K31/529	.....forming part of bridged ring systems [7]		HB	CC	4C086

A61K31/53	...having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine (melarsoprol A61K 31/555) [2]		HB	CC	4C086

A61K31/535	...having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines [2]		HB	CC	4C086

A61K31/5355	....Non-condensed oxazines containing further heterocyclic rings [7]		HB	CC	4C086

A61K31/536	....ortho- or peri-condensed with carbocyclic ring systems [7]		HB	CC	4C086

A61K31/5365	....ortho- or peri-condensed with heterocyclic ring systems [7]		HB	CC	4C086

A61K31/537	....spiro-condensed or forming part of bridged ring systems [7]		HB	CC	4C086

A61K31/5375	....1,4-Oxazines, e.g. morpholine [7]		HB	CC	4C086

A61K31/5377	.....not condensed and containing further heterocyclic rings, e.g. timolol [7]		HB	CC	4C086

A61K31/538	.....ortho- or peri-condensed with carbocyclic ring systems [7]		HB	CC	4C086

A61K31/5383	.....ortho- or peri-condensed with heterocyclic ring systems [7]		HB	CC	4C086

A61K31/5386	.....spiro-condensed or forming part of bridged ring systems [7]		HB	CC	4C086

A61K31/539	....having two or more oxygen atoms in the same ring, e.g dioxazines [7]		HB	CC	4C086

A61K31/5395	....having two or more nitrogen atoms in the same ring, e.g. oxadiazines [7]		HB	CC	4C086

A61K31/54	...having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame [2]		HB	CC	4C086

A61K31/541	....Non-condensed thiazines containing further heterocyclic rings [7]		HB	CC	4C086

A61K31/5415	....ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam [7]		HB	CC	4C086

A61K31/542	....ortho- or peri-condensed with heterocyclic ring systems [7]		HB	CC	4C086

A61K31/545	.....Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula [figure], e.g. cephalosporins, cefaclor, cephalexine [2,6]		HB	CC	4C086

A61K31/546	......containing further heterocyclic rings, e.g. cephalothin [7]		HB	CC	4C086

A61K31/547	....spiro-condensed or forming part of bridged ring systems [7]		HB	CC	4C086

A61K31/548	....having two or more sulfur atoms in the same ring [7]		HB	CC	4C086

A61K31/549	....having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide [7]		HB	CC	4C086

A61K31/55	...having seven-membered rings, e.g. azelastine, pentylenetetrazole [2]		HB	CC	4C086

A61K31/551	....having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep [7]		HB	CC	4C086

A61K31/5513	.....1,4-Benzodiazepines, e.g. diazepam [7]		HB	CC	4C086

A61K31/5517	......condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam [7]		HB	CC	4C086

A61K31/553	....having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine [7]		HB	CC	4C086

A61K31/554	....having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem [7]		HB	CC	4C086

A61K31/555	..containing heavy metals, e.g. hemin, hematin, melarsoprol [2]		HB	CC	4C086

A61K31/557	.Eicosanoids, e.g. leukotrienes [3,7]		HB	CC	4C086

A61K31/5575	..having a cyclopentane ring, e.g. prostaglandin E₂, prostaglandin F_2-alpha [7]		HB	CC	4C086

A61K31/5578	..having a pentalene ring system, e.g. carbacyclin, iloprost [7]		HB	CC	4C086

A61K31/558	..having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes [7]		HB	CC	4C086

A61K31/5585	...having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin [7]		HB	CC	4C086

A61K31/559	..having heterocyclic rings containing hetero atoms other than oxygen [7]		HB	CC	4C086

A61K31/56	.Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids	(Note)/(Index)	HB	CC	4C086

A61K31/565	..not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol [2]		HB	CC	4C086

A61K31/566	...having an oxo group in position 17, e.g. oestrone [7]		HB	CC	4C086

A61K31/567	...substituted in position 17 alpha, e.g. mestranol, norethandrolone [7]		HB	CC	4C086

A61K31/568	...substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone [7]		HB	CC	4C086

A61K31/5685	....having an oxo group in position 17, e.g. androsterone [7]		HB	CC	4C086

A61K31/569	....substituted in position 17 alpha, e.g. ethisterone [7]		HB	CC	4C086

A61K31/57	..substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone [2006.01]		HB	CC	4C086

A61K31/573	...substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone [2006.01]		HB	CC	4C086

A61K31/575	..substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol [2]		HB	CC	4C086

A61K31/58	..containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin (digitoxin A61K 31/704) [2006.01]		HB	CC	4C086

A61K31/585	...containing lactone rings, e.g. oxandrolone, bufalin [2]		HB	CC	4C086

A61K31/59	.Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems [2]		HB	CC	4C086

A61K31/592	..9,10-Secoergostane derivatives, e.g. ergocalciferol, vitamin D₂ [7]		HB	CC	4C086

A61K31/593	..9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D₃ [7]		HB	CC	4C086

A61K31/60	.Salicylic acid; Derivatives thereof [2]		HB	CC	4C086

A61K31/603	..having further aromatic rings, e.g. diflunisal [7]		HB	CC	4C086

A61K31/606	..having amino groups [7]		HB	CC	4C086

A61K31/609	..Amides, e.g. salicylamide [7]		HB	CC	4C086

A61K31/612	..having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid (fosfosal A61K 31/661) [7]		HB	CC	4C086

A61K31/616	...by carboxylic acids, e.g. acetylsalicylic acid [7]		HB	CC	4C086

A61K31/618	..having the carboxyl group in position 1 esterified, e.g. salsalate [7]		HB	CC	4C086

A61K31/621	...having the hydroxy group in position 2 esterified, e.g. benorylate [7]		HB	CC	4C086

A61K31/625	..having heterocyclic substituents, e.g. 4-salicyloylmorpholine (sulfasalazine A61K 31/635) [2,7]		HB	CC	4C086

A61K31/63	.Compounds containing para-N-benzene- sulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonohydrazide [2]		HB	CC	4C086

A61K31/635	..having a heterocyclic ring, e.g. sulfadiazine [2]		HB	CC	4C086

A61K31/64	.Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide [2]		HB	CC	4C086

A61K31/65	.Tetracyclines [2]		HB	CC	4C086

A61K31/655	.Azo (—N=N—), diazo (=N₂), azoxy (3) or diazoamino (—N=N—N<) compounds [2]		HB	CC	4C086

A61K31/66	.Phosphorus compounds [2]		HB	CC	4C086

A61K31/661	..Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion [7]		HB	CC	4C086

A61K31/6615	...Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid [7]		HB	CC	4C086

A61K31/662	..Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon [7]		HB	CC	4C086

A61K31/663	...Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid [7]		HB	CC	4C086

A61K31/664	..Amides of phosphorus acids [7]		HB	CC	4C086

A61K31/665	..having oxygen as a ring hetero atom, e.g. fosfomycin [2]		HB	CC	4C086

A61K31/67	..having sulfur as a ring hetero atom [2]		HB	CC	4C086

A61K31/675	..having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate [2]		HB	CC	4C086

A61K31/683	..Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols [7]		HB	CC	4C086

A61K31/685	...one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin [2,7]		HB	CC	4C086

A61K31/688	...both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins [7]		HB	CC	4C086

A61K31/69	.Boron compounds [2]		HB	CC	4C086

A61K31/695	.Silicon compounds [2]		HB	CC	4C086

A61K31/70	.Carbohydrates; Sugars; Derivatives thereof (sorbitol A61K 31/047)	(Note)/(Index)	HB	CC	4C086

A61K31/7004	..Monosaccharides having only carbon, hydrogen and oxygen atoms [7]		HB	CC	4C086

A61K31/7008	..Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine [7]		HB	CC	4C086

A61K31/7012	..Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid (gluconic acid A61K 31/191; ascorbic acid A61K 31/375) [7]		HB	CC	4C086

A61K31/7016	..Disaccharides, e.g. lactose, lactulose (lactobionic acid A61K 31/7032) [7]		HB	CC	4C086

A61K31/702	..Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages [7]		HB	CC	4C086

A61K31/7024	..Esters of saccharides [7]		HB	CC	4C086

A61K31/7028	..Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages [7]		HB	CC	4C086

A61K31/7032	...attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyl-diacylglycerides, lactobionic acid, gangliosides [7]		HB	CC	4C086

A61K31/7034	...attached to a carbocyclic compound, e.g. phloridzin [7]		HB	CC	4C086

A61K31/7036	....having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins [7]		HB	CC	4C086

A61K31/704	....attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin [7]		HB	CC	4C086

A61K31/7042	..Compounds having saccharide radicals and heterocyclic rings [7]		HB	CC	4C086

A61K31/7048	...having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin [7]		HB	CC	4C086

A61K31/7052	...having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides [7]		HB	CC	4C086

A61K31/7056	....containing five-membered rings with nitrogen as a ring hetero atom [7]		HB	CC	4C086

A61K31/706	....containing six-membered rings with nitrogen as a ring hetero atom [7]		HB	CC	4C086

A61K31/7064	.....containing condensed or non-condensed pyrimidines [7]		HB	CC	4C086

A61K31/7068	......having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid [7]		HB	CC	4C086

A61K31/7072	.......having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine [7]		HB	CC	4C086

A61K31/7076	......containing purines, e.g. adenosine, adenylic acid [7]		HB	CC	4C086

A61K31/708	.......having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid [7]		HB	CC	4C086

A61K31/7084	..Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide [7]		HB	CC	4C086

A61K31/7088	..Compounds having three or more nucleosides or nucleotides [7]		HB	CC	4C086

A61K31/7105	...Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links [7]		HB	CC	4C086

A61K31/711	...Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links [7]		HB	CC	4C086

A61K31/7115	...Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine [7]		HB	CC	4C086

A61K31/712	...Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose [7]		HB	CC	4C086

A61K31/7125	...Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters [7]		HB	CC	4C086

A61K31/713	...Double-stranded nucleic acids or oligonucleotides [7]		HB	CC	4C086

A61K31/7135	..Compounds containing heavy metals [7]		HB	CC	4C086

A61K31/714	...Cobalamins, e.g. cyanocobalamin, vitamin B₁₂ [7]		HB	CC	4C086

A61K31/715	..Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters [2]		HB	CC	4C086

A61K31/716	...Glucans [7]		HB	CC	4C086

A61K31/717	....Celluloses [7]		HB	CC	4C086

A61K31/718	....Starch or degraded starch, e.g. amylose, amylopectin [7]		HB	CC	4C086

A61K31/719	....Pullulans [7]		HB	CC	4C086

A61K31/721	....Dextrans [7]		HB	CC	4C086

A61K31/722	....Chitin; Chitosan [7]		HB	CC	4C086

A61K31/723	....Xanthans [7]		HB	CC	4C086

A61K31/724	....Cyclodextrins [7]		HB	CC	4C086

A61K31/726	...Glycosaminoglycans, i.e. mucopolysaccharides (chondroitin sulfate, dermatan sulfate A61K 31/737) [7]		HB	CC	4C086

A61K31/727	....Heparin; Heparan [7]		HB	CC	4C086

A61K31/728	....Hyaluronic acid [7]		HB	CC	4C086

A61K31/729	...Agar; Agarose; Agaropectin [7]		HB	CC	4C086

A61K31/731	...Carrageenans [7]		HB	CC	4C086

A61K31/732	...Pectin [7]		HB	CC	4C086

A61K31/733	...Fructosans, e.g. inulin [7]		HB	CC	4C086

A61K31/734	...Alginic acid [7]		HB	CC	4C086

A61K31/736	...Glucomannans or galactomannans, e.g locust bean gum, guar gum [7]		HB	CC	4C086

A61K31/737	...Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate (A61K 31/727 takes precedence) [7]		HB	CC	4C086

A61K31/738	...Cross-linked polysaccharides [7]		HB	CC	4C086

A61K31/739	...Lipopolysaccharides [7]		HB	CC	4C086

A61K31/74	.Synthetic polymeric materials [2]		HB	CC	4C086

A61K31/745	..Polymers of hydrocarbons [2]		HB	CC	4C086

A61K31/75	...of ethene [2]		HB	CC	4C086

A61K31/755	..Polymers containing halogen [2]		HB	CC	4C086

A61K31/76	...of vinyl chloride [2]		HB	CC	4C086

A61K31/765	..Polymers containing oxygen [2]		HB	CC	4C086

A61K31/77	...of oxiranes [2]		HB	CC	4C086

A61K31/775	...Phenolic resins [2]		HB	CC	4C086

A61K31/78	...of acrylic acid or derivatives thereof [2]		HB	CC	4C086

A61K31/785	..Polymers containing nitrogen [2]		HB	CC	4C086

A61K31/787	...containing heterocyclic rings having nitrogen as a ring hetero atom [7]		HB	CC	4C086

A61K31/79	....Polymers of vinyl pyrrolidone [2]		HB	CC	4C086

A61K31/795	..Polymers containing sulfur [2]		HB	CC	4C086

A61K31/80	..Polymers containing hetero atoms not provided for in groups A61K 31/755-A61K 31/795 [2]		HB	CC	4C086

This page displays all 「FI」 in main group A61K31/00.	HB:Handbook
	CC:Concordance